With this mind, it has been hard for the banking industry to support legal marijuana businesses.
With this mind, it has been hard for the banking industry to support legal marijuana businesses.
SinglePoint (OTC: SING) continues to pursue strategic opportunities to widen its foothold in the cannabis industry while hedging itself against potential risks regarding the legality of marijuana.
ChineseInvestors.com, Inc. (OTCQB: CIIX) is launching a line of hemp-infused skin care products in China. The cannabinoid content of the line makes these products more than just cosmetics.
Before the opening bell, CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announced the release of an exclusive interview with Singlepoint, Inc. (OTC: SING) CEO Greg Lambrecht.
Through building a diversified holding base, SinglePoint, Inc. (OTC: SING) has developed from a full-service mobile technology provider to a publicly traded holding company, and its SingleSeed subsidiary is working to solve an issue that is currently plaguing legal cannabis businesses: a lack of traditional banking options.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) achieved working capital of $43 million from multiple financings, including private placements and strategic partnerships, during the six months ended June 30, 2017.
As the cannabis industry continues to flourish, many publicly traded companies are finding ample opportunities to thrive.
Singlepoint, Inc. (OTC: SING), a publicly traded holding company, offers payment solutions to the cannabis industry through its SingleSeed subsidiary.
Before the opening bell, Singlepoint, Inc. (OTC: SING) was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon.
India Globalization Capital, Inc. (NYSE MKT: IGC) is racing ahead with its preparation of medical trials for four drug candidates that treat a variety of debilitating conditions.
The future of cannabinoid-based medicine hinges on such innovations which is: the ability to produce cannabinoids identical to those found in nature in a safe, consistent and economical fashion to advance cannabis-based drug development.
If you have any doubt that InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is on the right track as it moves to protect its biosynthesis technology for cannabinoids, then a word from a famed figure may make you change your mind.
The innovative biotech has developed a lipid-based system that delivers bioactive compounds more efficiently.
From Main Street to Wall Street, the cannabis industry is branching out into a variety of business opportunities for not only the key players involved but smaller startup firms as well.